TP53INP2-dependent activation of muscle autophagy ameliorates sarcopenia and promotes healthy aging.

ABSTRACT

Sarcopenia is a major contributor to disability in older adults, and thus, it is key to elucidate the mechanisms underlying its development. Increasing evidence suggests that impaired macroautophagy/autophagy contributes to the development of sarcopenia. However, the mechanisms leading to reduced autophagy during aging remain largely unexplored, and whether autophagy activation protects from sarcopenia has not been fully addressed. Here we show that the autophagy regulator TP53INP2/TRP53INP2 is decreased during aging in mouse and human skeletal muscle. Importantly, chronic activation of autophagy by muscle-specific overexpression of TRP53INP2 prevents sarcopenia and the decline of muscle function in mice. Acute re-expression of TRP53INP2 in aged mice also improves muscle atrophy, enhances mitophagy, and reduces ROS production. In humans, high levels of TP53INP2 in muscle are associated with increased muscle strength and healthy aging. Our findings highlight the relevance of an active muscle autophagy in the maintenance of muscle mass and prevention of sarcopenia.Abbreviation ATG7 autophagy related 7; BMI body mass index; EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1; MAP1LC3/LC3 microtubule associated protein 1 light chain 3; ROS reactive oxygen species; TP53INP2 tumor protein p53 inducible nuclear protein 2; WT wild type.